Satoskar Anjali A, Lehman Amy M, Nadasdy Gyongyi M, Sedmak Daniel D, Pesavento Todd E, Henry Mitchell L, Pelletier Ronald P, Ferguson Ronald M, Nadasdy Tibor
Department of Pathology, The Ohio State University, Columbus, OH, USA.
Clin Transplant. 2008 Jan-Feb;22(1):61-7. doi: 10.1111/j.1399-0012.2007.00745.x.
In the early post-transplant period, renal allograft rejection with diffuse peritubular capillary (PTC) C4d deposition predicts poor graft survival. In the late post-transplant setting, that is, one or more yr after transplantation, the implication of diffuse PTC C4d deposition is still a topic of debate. The purpose of our study was to see if diffuse PTC C4d deposition, in late acute rejection (LAR), occurring more than one yr post-transplant, has any impact on graft survival and function.
We selected cases, both cadaveric as well as living donor renal transplant recipients, in whom acute rejection with PTC C4d deposition was first detected after the first year post-transplant. Recipients with multiple acute rejection episodes during the first year post-transplant were excluded from the study. The first biopsy diagnosed with LAR was considered the index biopsy (n = 40). We formed two groups: group 1, C4d-positive LAR (n = 20), and group 2, C4d-negative LAR (n = 20). Groups were matched for maintenance and post-rejection immunosuppressive therapy, baseline serum creatinine levels before the time of the index biopsy, time from transplant to index biopsy, as well as chronic allograft damage index (CADI) score in the index biopsies. We compared the rate of graft loss, and the graft function of the surviving grafts at the end of the study period, as well as histologic parameters in the index biopsy specimens between the two groups. The mean follow-up period was 20 months.
No significant differences in the rate of graft loss or graft function were found between groups 1 and 2 at the end of the follow-up period. Histologically, PTC margination and transplant glomerulopathy were more common in the C4d-positive group, and this difference was statistically significant. There was no statistically significant difference in the degree of plasma cell infiltrates.
Unlike in the acute setting, the presence or absence of PTC C4d staining in renal allografts with LAR may not have a predictive value regarding graft outcome.
在移植后的早期,伴有弥漫性肾小管周围毛细血管(PTC)C4d沉积的肾移植排斥反应预示着移植肾存活不佳。在移植后的晚期,即移植后一年或更长时间,弥漫性PTC C4d沉积的意义仍是一个有争议的话题。我们研究的目的是观察移植后一年以上发生的晚期急性排斥反应(LAR)中弥漫性PTC C4d沉积是否对移植肾存活和功能有任何影响。
我们选择了尸体供肾和活体供肾肾移植受者病例,这些病例在移植后第一年首次检测到伴有PTC C4d沉积的急性排斥反应。移植后第一年有多次急性排斥反应发作的受者被排除在研究之外。首次诊断为LAR的活检被视为索引活检(n = 40)。我们形成了两组:第1组,C4d阳性LAR(n = 20),和第2组,C4d阴性LAR(n = 20)。两组在维持和排斥反应后的免疫抑制治疗、索引活检前的基线血清肌酐水平、从移植到索引活检的时间以及索引活检中的慢性移植肾损伤指数(CADI)评分方面进行匹配。我们比较了两组在研究期结束时的移植肾丢失率、存活移植肾的功能以及索引活检标本中的组织学参数。平均随访期为20个月。
随访期结束时,第1组和第2组在移植肾丢失率或移植肾功能方面未发现显著差异。组织学上,PTC边缘化和移植性肾小球病在C4d阳性组中更常见,且这种差异具有统计学意义。浆细胞浸润程度没有统计学显著差异。
与急性情况不同,伴有LAR的肾移植中PTC C4d染色的有无可能对移植肾结局没有预测价值。